BRIEF published on 01/21/2025 at 21:05, 1 year ago Fundraising of €0.25 million by Néovacs Fundraising Shareholder Dilution Néovacs OCEANE-BSA Kinoid® Research
BRIEF published on 01/21/2025 at 21:05, 1 year ago Levée de fonds de 0,25 M€ par Néovacs Levée De Fonds Néovacs OCEANE-BSA Dilution Actionnaire Recherche Kinoïde®
PRESS RELEASE published on 01/21/2025 at 21:00, 1 year ago Levée de fonds de 0,25 MEUR Néovacs annonce une levée de fonds de 0,25 M€ par l'émission d'OCEANE-BSA pour financer la recherche sur les allergies et les investissements en BioTech et MedTech Biotech MedTech Levée De Fonds Néovacs OCEANE-BSA
BRIEF published on 01/15/2025 at 20:05, 1 year ago Adjustment of the nominal value at Neovacs Investment Capital Reduction Nominal Value Néovacs Stock Market Shares
BRIEF published on 01/15/2025 at 20:05, 1 year ago Ajustement de la valeur nominale chez Néovacs Investissement Valeur Nominale Néovacs Actions Boursières Réduction Capital
PRESS RELEASE published on 01/15/2025 at 20:00, 1 year ago Ajustement de la valeur nominale Néovacs réduit la valeur nominale de son action de 1 euro à 0,50 euro, suite à une réduction de capital motivée par des pertes. La société française développe des thérapies pour maladies inflammatoires Biopharmaceutique Réduction De Capital Maladies Inflammatoires Valeur Nominale Néovacs
BRIEF published on 12/18/2024 at 08:35, 1 year 1 month ago Levée de fonds par Néovacs Biotechnologie Levée De Fonds Dilution Néovacs OCEANE-BSA
BRIEF published on 12/18/2024 at 08:35, 1 year 1 month ago Fundraising by Neovacs Biotechnology Fundraising Dilution Néovacs OCEANE-BSA
PRESS RELEASE published on 12/18/2024 at 08:30, 1 year 1 month ago Levée de fonds de 0,25 MEUR Néovacs annonce une levée de fonds de 0,25 M€ pour financer le programme de recherche Kinoïde® sur les allergies et renforcer les investissements en BioTech et MedTech Biotech Levée De Fonds Néovacs Kinoïde® Allergies
BRIEF published on 09/18/2024 at 20:05, 1 year 4 months ago Fundraising of €0.25 million by Néovacs Biotechnology Fundraising Investment Dilution OCEANE-BSA
Published on 02/14/2026 at 01:00, 1 day 14 hours ago Orogen Royalties Announces Annual Equity Compensation Grant
Published on 02/13/2026 at 22:15, 1 day 17 hours ago Storm Completes Sale of Miminiska Project for $5.8M and Outlines Plans for 2026
Published on 02/13/2026 at 17:45, 1 day 21 hours ago Eldorado Gold Closes $2.4 Million Strategic Investment in Gemdale Gold
Published on 02/13/2026 at 14:35, 2 days ago Datametrex Received $500,000 Purchase Order For Data Centre Solutions
Published on 02/15/2026 at 11:43, 3 hours 39 minutes ago EQS-Adhoc: The Management Board of Hapag-Lloyd Aktiengesellschaft confirms negotiations regarding an acquisition of Zim Integrated Shipping Services Ltd.
Published on 02/15/2026 at 11:05, 4 hours 17 minutes ago WePlay Debuts in German Market with "The Little Prince" Special Valentine's Day Collaboration
Published on 02/15/2026 at 09:35, 5 hours 47 minutes ago Canary Islands at the Berlinale European Film Market with more than 40 professionals from the islands
Published on 02/14/2026 at 16:30, 22 hours 52 minutes ago Milano Cortina 2026 Licensed Candies Released Globally
Published on 02/14/2026 at 06:05, 1 day 9 hours ago The 139th Canton Fair Promotion Conferences to Be Held in Germany and Morocco, Highlighting Targeted Industry Opportunities
Published on 02/13/2026 at 18:05, 1 day 21 hours ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/01/2026
Published on 02/13/2026 at 18:05, 1 day 21 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/01/2026
Published on 02/13/2026 at 17:50, 1 day 21 hours ago Number of shares and voting rights - January 2026 (In French only)
Published on 02/13/2026 at 17:50, 1 day 21 hours ago Nombre total d'actions et droits de vote - janvier 2026
